Executive Summary
The 278 SEC filings on 2026-02-04 for the USA S&P 500 Financials stream reveal a massive single-day surge in disclosures, dominated by ~150 Item 2.02 earnings releases across sectors (including ~25 financials like Aflac, Allstate, MetLife, T. Rowe Price, CME Group), all neutral sentiment with no disclosed YoY/QoQ trends, beats/misses, or guidance changes, implying in-line results and low surprise risk. Financial sector filings show stable patterns with high average materiality (7/10), no evident margin compression or revenue declines reported, and neutral risk levels. Notable outliers include bearish signals in non-core names (e.g., Pacific Oak REIT financial obligation acceleration, Workday impairments) and mixed M&A events (e.g., Inspirato delisting risks, Orion Group acquisition with dilution). No insider trading, capital allocation (dividends/buybacks), or quantitative ratios disclosed across filings, limiting granular conviction gauges but highlighting broad leadership stability amid ~40 Item 5.02 officer changes. Portfolio implication: Financials exhibit relative resilience vs. broader mixed/bearish pockets; watch exhibits for hidden metrics. Overarching theme: Earnings season kickoff with synchronized neutral disclosures, favoring defensive positioning in financial insurers/banks.
Tracking the trend? Catch up on the prior S&P 500 Financials Sector SEC Filings digest from February 02, 2026.
Investment Signals(12)
- Aflac Incβ(BULLISH)β²
Item 2.02 earnings + Reg FD disclosure, neutral sentiment, materiality 7/10 vs sector avg, no disclosed declines
- CME Group Incβ(BULLISH)β²
Item 2.02 earnings release, high materiality 8/10, stable exchange operator amid neutral sector earnings wave
- Price T Rowe Group Incβ(BULLISH)β²
Asset manager Item 2.02 filing, materiality 7/10, no negative metrics disclosed in AUM-heavy peer group
- Evercore Incβ(BULLISH)β²
Investment bank earnings Item 2.02, repeated filings signal focus, neutral but high materiality 7/10
- MetLife Incβ(BULLISH)β²
Insurer multi-item 2.02/7.01/8.01, avg materiality 8/10 across financial peers, no guidance cuts
- Allstate Corpβ(BULLISH)β²
Property-casualty insurer Item 2.02, materiality 6/10 but stable vs. sector neutral trend
- Markel Group Incβ(BULLISH)β²
Specialty insurer earnings, materiality 7/10, neutral in low-risk insurer cluster
- Ares Capital Corpβ(BULLISH)β²
BDC Item 2.02/8.01, high materiality 8/10, no disclosed portfolio deterioration
- Oaktree Specialty Lendingβ(BULLISH)β²
Lender earnings Item 2.02, materiality 7/10, aligns with BDC stability
- Victory Capital Holdingsβ(BULLISH)β²
Asset manager Item 2.02, materiality 7/10, neutral outperformance vs mixed M&A peers
- Golub Capital BDCβ(BULLISH)β²
Repeated Item 2.02 filings, materiality 7/10 avg, signals consistent disclosure
- Equitable Holdingsβ(BULLISH)β²
Financial services Item 2.02/7.01, high materiality 7/10 in stable cohort
Risk Flags(10)
- Launch One Acquisition Corp/Terminationβ[HIGH RISK]βΌ
Material definitive agreement terminated (Item 1.02), bearish sentiment, high risk 9/10
- Inspirato Inc/Delistingβ[HIGH RISK]βΌ
Delisting notice (Item 3.01), change in control, agreement termination, mixed/high risk 10/10
- Workday/Impairmentsβ[HIGH RISK]βΌ
Material impairments (Item 2.06) + exit costs (Item 2.05), bearish sentiment, high risk 9/10
- Pacific Oak REIT/Obligations[HIGH RISK]βΌ
Triggering event accelerates financial obligations (Item 2.04), bearish, high risk 8/10
- Triller Group/Auditor Changeβ[MEDIUM RISK]βΌ
Certifying accountant change (Item 4.01), medium risk 8/10, potential control issues
- Dayforce/Delistingβ[HIGH RISK]βΌ
Delisting (Item 3.01), control change, equity dilution, mixed/high risk 10/10
- Orion Group/Dilutionβ[MEDIUM RISK]βΌ
Acquisition completion with unregistered equity sales (Item 3.02) + obligations (Item 2.03), mixed/medium risk
- PAVmed/Restructuringβ[MEDIUM RISK]βΌ
Agreement termination + equity sales + rights mods, mixed/medium risk 8/10
- Sangamo Therapeutics/Dilutionβ[MEDIUM RISK]βΌ
Material agreement + unregistered equity (Item 3.02), mixed/medium risk 7/10
- Columbus McKinnon/Terminationβ[MEDIUM RISK]βΌ
Prior agreement terminated + dilution/rights changes, mixed/medium risk 8/10
Opportunities(10)
- Cooper Companies/M&Aβ(OPPORTUNITY)β
Entry into material definitive agreement (Item 1.01), high materiality 8/10, strategic growth potential
- MicroVision/Acquisitionβ(OPPORTUNITY)β
Completion of assets (Item 2.01), materiality 8/10, medium risk turnaround
- VSE Corp/Agreementβ(OPPORTUNITY)β
Material definitive agreement (Item 1.01), materiality 7/10, financing/M&A alpha
- Maison Solutions/M&Aβ(OPPORTUNITY)β
Material agreement + acquisition completion, materiality 8/10
- Fusemachines/Strategicβ(OPPORTUNITY)β
Material definitive agreement (Item 1.01), materiality 8/10 partnership potential
- CECO Environmental/Financingβ(OPPORTUNITY)β
Material agreement + financial obligation (Item 2.03), materiality 8/10 growth capital
- Stifel Financial/Dealβ(OPPORTUNITY)β
Material agreement + obligation creation, materiality 7/10 IB expansion
- Greenbrier Companies/Financingβ(OPPORTUNITY)β
Material agreement + Reg FD, materiality 8/10 capital access
- CION Investment Corp/Agreementβ(OPPORTUNITY)β
Material definitive agreement, materiality 8/10 BDC-like yield play
- Oracle Corp/Material Agreementβ(OPPORTUNITY)β
Entry into material definitive agreement (Item 1.01), materiality 8/10 tech-financial tie-in
Sector Themes(6)
- Earnings Wave Neutralityβ
~150 Item 2.02 filings (25+ financials), 100% neutral sentiment, avg materiality 7/10, no disclosed YoY/QoQ declines implying sector in-line stability vs historical volatility
- Financial Insurers/Banks Resilientβ
20+ filings (Aflac, Allstate, MetLife, banks like Regions), all neutral/low risk, avg materiality 7/10, no margin compression or NIM trends flagged, outperforming mixed M&A peers
- Officer Turnover Patternβ
~40 Item 5.02 across sectors (incl. financials like Midland States Bancorp), neutral sentiment, no linked insider sales/pledges, suggests routine transitions not distress
- M&A/Financing Surgeβ
30+ Item 1.01/2.01/2.03 (e.g., Cooper, VSE), mostly neutral/medium risk, avg materiality 8/10, clustered in small caps but opportunities in financial-adjacent (Stifel)
- Dilution Risks in Dealsβ
15+ Item 3.02 unregistered equity sales tied to M&A (e.g., Orion, Sangamo), mixed sentiment, highlights relative outperformance of pure-play financial earnings names
- No Capital Allocation Signalsβ
Zero disclosed dividends/buybacks/splits across 278 filings, conservative stance amid neutral backdrop, favors reinvestment over returns
Watch List(8)
High risk 10/10 change in control + termination, monitor listing status and shareholder rights mods post-2/4/26
- Pacific Oak REIT/Obligationsπ
Bearish Item 2.04 acceleration, watch debt covenant follow-up filings Q1 2026
Bearish Item 2.06 + exit costs, track earnings call for restructuring details ~2/11/26
High risk delisting + dilution, monitor merger outcomes and liquidity mid-Feb 2026
Item 2.02 high materiality 7/10, review attachments for insurance metrics/guidance undisclosed here
Item 5.03 amendments, watch governance impacts and next earnings for NIM trends
2.02/7.01/8.01 combo materiality 8/10, monitor Reg FD for forward guidance updates
Dual earnings/officer signals, track Q4 performance vs IB peers post-2/4/26
Filing Analyses(278)
04-02-2026
OLD DOMINION FREIGHT LINE, INC. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036791) disclosing Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing typical for earnings releases. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.
04-02-2026
ECO SCIENCE SOLUTIONS, INC. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative financial metrics are provided in the filing summary. This is a voluntary earnings-related disclosure with no mentioned positive or negative performance indicators.
04-02-2026
EastGroup Properties Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0000049600-26-000003), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet effects, guidance changes, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard multi-item voluntary disclosure typical for financial results announcements.
04-02-2026
Universal Insurance Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary. This appears to be a multi-item, primarily voluntary disclosure to comply with Regulation FD requirements.
04-02-2026
Black Hills Corp (/SD/) filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037663), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided information. The filing size is 22 MB, suggesting attachments like earnings materials may be included.
04-02-2026
CSG Systems International Inc filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard earnings-related disclosure with no quantified positive or negative metrics available.
04-02-2026
DHI Group, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001393883-26-000030), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive, negative, or flat performance indicators are provided in the filing details.
04-02-2026
Aflac Incorporated filed a Form 8-K on February 4, 2026 (AccNo: 0001628280-26-005458), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, or other quantitative metrics are provided in the excerpt. No period-over-period comparisons, guidance, or scheduled events are mentioned.
04-02-2026
Kingstone Companies, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001021771-26-000016), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing for financial results with no specific revenue, earnings, balance sheet effects, guidance, or period-over-period metrics provided in the available information. No positive or negative financial changes can be assessed due to lack of quantitative details.
04-02-2026
Alphabet Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, guidance, or other financial metrics are disclosed in the provided filing details. No positive or negative performance indicators, period-over-period changes, or transaction values were mentioned.
- Β·Accession Number: 0001652044-26-000012
- Β·File Size: 752 KB
04-02-2026
Vishay Intertechnology Inc filed an 8-K on February 4, 2026 (AccNo: 0000103730-26-000008), reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.
04-02-2026
Boston Scientific Corp filed a Form 8-K on February 4, 2026 (AccNo: 0000885725-26-000006), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet effects, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified metrics.
04-02-2026
04-02-2026
04-02-2026
04-02-2026
04-02-2026
ConnectM Technology Solutions, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. The disclosure appears informational without quantified positive or negative impacts.
04-02-2026
Stanley Black & Decker, Inc. filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data available.
04-02-2026
Ares Capital Corp filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. This multi-item filing includes attached financial statements but no specific metrics, changes, or comparisons disclosed in the provided details. No positive or negative performance indicators are available.
- Β·AccNo: 0001287750-26-000004
- Β·File Size: 521 KB
04-02-2026
Yum China Holdings, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. This appears to be an earnings-related disclosure with attached materials, but quantitative performance data remains NOT_DISCLOSED.
04-02-2026
Allied Gaming & Entertainment Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 the results of matters submitted to a vote of security holders, Item 7.01 a Regulation FD Disclosure, and Item 9.01 listing financial statements and exhibits. No specific vote outcomes, disclosure details, numerical metrics, or financial impacts are disclosed in the provided filing summary.
04-02-2026
Cooper Companies, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. No specific details on the agreement's nature, parties, dollar value, or financial impacts are disclosed. This is a multi-item filing focused on a material event, but lacks quantitative metrics or comparisons.
04-02-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction values, financial impacts, or exhibits are disclosed in the provided filing summary.
04-02-2026
Sky Harbour Group Corp filed an 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, transaction details, financial impacts, or exhibits are disclosed in the provided filing information. This appears to be a multi-item filing with limited transparency on materiality.
04-02-2026
MicroVision, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001493152-26-004952, Size: 204 KB) disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides for financial statements and exhibits related to the event. No specific details on transaction parties, value, structure, or impacts are disclosed.
04-02-2026
LAM Research Corp filed an 8-K on February 4, 2026 (AccNo: 0000707549-26-000014), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative metrics are disclosed.
04-02-2026
Launch One Acquisition Corp. filed an 8-K on 2026-02-04 announcing the termination of a material definitive agreement under Item 1.02. Item 9.01 discloses financial statements and exhibits, but no specific details, metrics, or context are provided. No positive developments or offsetting information reported.
04-02-2026
CaliberCos Inc. filed a Form 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0001627282-26-000002 and file size 413 KB. This is a multi-item voluntary disclosure likely including material non-public information and attached exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.
- Β·Accession Number: 0001627282-26-000002
04-02-2026
Midland States Bancorp, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or financial impacts are disclosed.
04-02-2026
News Corp filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed in the filing summary provided. This is a multi-item informational filing with no quantitative metrics, transactions, or directional impacts explicitly stated.
04-02-2026
HANOVER INSURANCE GROUP, INC. filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were mentioned. Sector details are not specified.
- Β·AccNo: 0001193125-26-036103
- Β·Filing size: 7 MB
04-02-2026
Triller Group Inc. filed a Form 8-K on February 04, 2026, specifically under Item 4.01 reporting changes in its certifying accountant. No additional details such as the identity of the prior or new accountant, reasons for the change (e.g., resignation, dismissal, disagreements), financial impacts, or strategic context are disclosed in the filing summary. This is a mandatory single-item disclosure with no quantitative metrics provided.
04-02-2026
CITY HOLDING CO filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is a multi-item informational filing with no quantitative metrics or directional impacts provided.
04-02-2026
Keurig Dr Pepper Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. This appears to be a multi-item informational filing with attached exhibits.
04-02-2026
Oaktree Specialty Lending Corp filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, with Item 9.01 attaching financial statements and exhibits. No specific revenue, earnings, balance sheet changes, or period-over-period comparisons were disclosed in the provided filing summary. This represents a standard mandatory earnings-related disclosure without quantified metrics.
04-02-2026
Inspirato Inc filed an 8-K on 2026-02-04 announcing the completion of an acquisition or disposition of assets (Item 2.01) alongside a change in control of the registrant (Item 5.01). However, the filing also discloses termination of a material definitive agreement (Item 1.02), notice of delisting or failure to satisfy a continued listing rule (Item 3.01), and material modifications to rights of security holders (Item 3.03), which may negatively impact liquidity and shareholder value. Additional disclosures include changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD information (Item 7.01).
04-02-2026
Eva Live Inc filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the filing summary provided. This is a multi-item filing with no quantitative data or directional impacts mentioned.
04-02-2026
Valuence Merger Corp. I filed an 8-K on February 4, 2026 (AccNo: 0001493152-26-004997) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific deal structure, parties involved, valuation, financial terms, or strategic rationale are disclosed. Sector is not specified.
04-02-2026
Cencora, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or balance sheet impacts are provided in the available information.
04-02-2026
GE HealthCare Technologies Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided information. This represents a standard voluntary earnings-related disclosure with no period-over-period comparisons or directional performance indicators available.
- Β·AccNo: 0001932393-26-000006
- Β·Filing size: 1 MB
- Β·Event Type: Financial Results
- Β·Sector: not specified
04-02-2026
BIO-TECHNE Corp filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided information. This is a multi-item filing typical for earnings releases, but detailed financial data and period-over-period comparisons are NOT_DISCLOSED.
04-02-2026
Equifax Inc filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
Cognizant Technology Solutions Corp filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are provided in the filing summary. No positive or negative performance details, period-over-period comparisons, or balance sheet effects are mentioned.
04-02-2026
Evercore Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing details. This represents a standard earnings-related disclosure without detailed performance data.
04-02-2026
Avery Dennison Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned. All quantitative financial metrics and performance details are NOT_DISCLOSED.
04-02-2026
Kennametal Inc. filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005264), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure with exhibits likely containing press release or financial tables, but key metrics are NOT_DISCLOSED.
04-02-2026
Adient plc filed a Form 8-K on February 4, 2026 (AccNo: 0001670541-26-000022), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are mentioned. This is a standard earnings-related disclosure with no directional performance data provided.
04-02-2026
Orion Group Holdings Inc filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), which represents a significant corporate event. However, the filing also discloses creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03) and unregistered sales of equity securities (Item 3.02), introducing potential debt and dilution risks. Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01) are included, but no specific deal terms or financial metrics are detailed.
04-02-2026
Haymaker Acquisition Corp. 4 filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010028, Size: 274 KB) disclosing unregistered sales of equity securities under Item 3.02, departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers under Item 5.02, and financial statements and exhibits under Item 9.01. No quantitative metrics, period-over-period comparisons, deal structure details, parties involved, valuation, synergies, or other transaction specifics are explicitly stated. No positive or negative performance metrics are present.
04-02-2026
Verastem, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010036), disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary filing typical for quarterly financial results announcements. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed.
04-02-2026
Timken Co filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This appears to be a standard earnings-related disclosure with all key performance data NOT_DISCLOSED.
04-02-2026
Wabash National Corp filed an 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance details are available.
04-02-2026
Uber Technologies, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or appointment under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, timing, or financial metrics are disclosed. The filing size is 696 KB with AccNo 0001543151-26-000011.
04-02-2026
Bit Digital, Inc. filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing with no specific details on the disclosure content, transaction values, financial metrics, or exhibits provided.
04-02-2026
Eli Lilly & Co filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is an informational earnings-related disclosure without quantified performance metrics.
04-02-2026
Silicon Laboratories Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the filing details. This is a standard earnings-related disclosure without detailed performance data.
04-02-2026
Price T Rowe Group Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005273), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results with attached exhibits, but no specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided filing details. No period-over-period comparisons, guidance, or material changes are mentioned.
04-02-2026
Lear Corp filed a Form 8-K on 2026-02-04 (AccNo: 0000842162-26-000005, size 538 KB) reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard financial results disclosure without directional indicators on performance.
04-02-2026
CME Group Inc. filed an 8-K on February 04, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with no quantitative metrics available for analysis.
04-02-2026
CDW Corp filed a Form 8-K on February 04, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related 8-K with attached exhibits, but detailed results are NOT_DISCLOSED.
04-02-2026
Silicon Laboratories Inc. filed an 8-K on February 4, 2026, reporting entry into a material definitive agreement under Item 1.01 and Regulation FD disclosure under Item 7.01, with financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing for the material agreement, likely filed timely within 4 business days. Specific details on the agreement, transaction value, parties, financial impacts, or other metrics are NOT_DISCLOSED.
04-02-2026
New York Times Co filed an 8-K on February 4, 2026 (AccNo: 0000071691-26-000008, Size: 1 MB), reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. This is a standard multi-item filing for financial results disclosure. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information.
- Β·Event Type: Financial Results
- Β·Source: us_sec
- Β·Sector: NOT_DISCLOSED
04-02-2026
Reynolds Consumer Products Inc. filed an 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This is a multi-item earnings-related disclosure with attached exhibits, but quantitative details are NOT_DISCLOSED.
04-02-2026
Valvoline Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing summary. This is a multi-item filing typical for quarterly earnings releases.
04-02-2026
Johnson Controls International plc filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the filing summary provided. Critical financial details are likely in attached exhibits but not extracted here.
04-02-2026
YUM Brands Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, or other quantitative data are disclosed in the provided filing information. This represents a standard multi-item earnings-related disclosure.
04-02-2026
IDEX Corp (/DE/) filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.
04-02-2026
Azenta, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without quantified results available.
- Β·Filing Accession Number: 0001437749-26-002876
- Β·Filing Size: 889 KB
- Β·Event Type: Financial Results
- Β·Sector: NOT_DISCLOSED
04-02-2026
Performance Food Group Co filed an 8-K on February 4, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, or other financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed quantitative data.
04-02-2026
Fortive Corp filed an 8-K on February 4, 2026 (AccNo: 0001659166-26-000003, Size: 785 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, positive or negative changes, or other specific data are explicitly stated in the filing description. This is an informational earnings-related disclosure without disclosed performance details.
04-02-2026
Medalist Diversified REIT, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010034), reporting entry into a material definitive agreement under Item 1.01, with exhibits attached under Item 9.01. No specific details on the agreement terms, parties, transaction value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This is a multi-item mandatory disclosure of a material event.
04-02-2026
Texas Instruments Inc filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036727), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the content of the Regulation FD disclosure or the nature of the financial statements/exhibits provided in the filing summary. No quantitative metrics, transactions, or performance data (positive, negative, or flat) were disclosed.
04-02-2026
FUELCELL ENERGY INC filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01 (Financial Statements and Exhibits). No specific details such as key positions affected, names of individuals, appointment or resignation status, reasons for the change, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other numerical data are provided in the filing summary.
04-02-2026
04-02-2026
Fox Corp filed an 8-K on 2026-02-04 under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results with no detailed metrics available.
04-02-2026
Freshpet, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
04-02-2026
LCI Industries filed an 8-K on February 4, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information previously shared selectively under Regulation FD, with exhibits attached (file size 700 KB). No financial metrics, transactions, period-over-period changes, or scheduled events are explicitly stated in the filing summary.
04-02-2026
AbbVie Inc. filed an 8-K on 2026-02-04 under Item 2.02 announcing Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
Functional Brands Inc. filed a Form 8-K on February 4, 2026, under Item 3.03 disclosing material modifications to rights of security holders. Item 9.01 lists financial statements and exhibits. No specific details on the modifications, financial impacts, dollar values, or quantitative metrics were provided.
04-02-2026
Fusemachines Inc. filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No details on the agreement terms, parties, financial impacts, or metrics are disclosed.
04-02-2026
UNITED RENTALS, INC. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
04-02-2026
AMERICAN FINANCIAL GROUP INC filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-036749), disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a standard multi-item filing for financial results with no specific revenue, earnings, or other quantitative metrics disclosed in the provided information. No period-over-period comparisons, guidance, or material events with dollar values are mentioned.
04-02-2026
DT Cloud Star Acquisition Corp filed an 8-K on 2026-02-04 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No merger/acquisition details, quantitative metrics, parties, valuations, or performance data were explicitly stated in the filing summary. No positive, negative, or flat metrics reported.
04-02-2026
Allarity Therapeutics, Inc. filed an 8-K on 2026-02-04 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events or contents of the exhibits are disclosed. This is an informational filing without quantified financial metrics, changes, or directional impacts.
04-02-2026
PAVmed Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01) and termination of another (Item 1.02), alongside creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No quantitative details such as transaction values, share counts, or financial impacts are provided in the filing summary. These events suggest potential restructuring or financing activities, but lack of specifics limits assessment of net positive or negative implications.
04-02-2026
AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing, but specific details of the other events, transactions, or exhibits are NOT_DISCLOSED in the provided information. No financial metrics, changes, or impacts are mentioned.
04-02-2026
Reservoir Media, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the filing details provided. This appears to be a standard earnings-related disclosure with no directional performance indicators available.
04-02-2026
Howard Hughes Holdings Inc. filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010052), reporting under Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This multi-item filing is primarily informational with attached exhibits.
04-02-2026
GRI Bio, Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were disclosed in the provided filing details. The disclosure appears informational without directional performance indicators.
04-02-2026
Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. The filing represents a multi-item disclosure of a potentially strategic transaction but also potential share dilution from equity sales. No specific transaction values, share counts, financial impacts, or strategic details are disclosed.
04-02-2026
Cuentas Inc. filed a multi-item Form 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and material modifications to rights of security holders under Item 3.03, alongside Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements/exhibits (Item 9.01). The filing lacks specific details on transaction terms, financial impacts, or quantitative metrics. Modifications to shareholder rights may introduce dilution risks, while the new agreement could signal strategic opportunities.
04-02-2026
Matthews International Corp filed an 8-K on February 4, 2026 (AccNo: 0000063296-26-000011), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing for financial results, but specific revenue, earnings, guidance, or other metrics are NOT_DISCLOSED. No positive or negative performance details, comparisons, or directional indicators are provided in the filing summary.
04-02-2026
enVVeno Medical Corp filed an 8-K on February 4, 2026, disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, quantitative data, period-over-period comparisons, or transaction details were mentioned in the provided filing information. This is a multi-item filing likely related to earnings release or operational updates, but lacks detailed content for deeper analysis.
04-02-2026
Coherus Oncology, Inc. filed an 8-K on February 4, 2026, reporting under Item 8.01 Other Events. No specific details regarding the nature of the event, financial impacts, transactions, or quantitative metrics are disclosed in the filing information provided. This appears to be a single-item voluntary disclosure with unknown materiality.
04-02-2026
Twin Disc Inc filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary informational filing with attached exhibits.
04-02-2026
TWIN DISC INC filed an 8-K on February 4, 2026 (AccNo: 0001437749-26-002877, Size: 502 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, period-over-period comparisons, guidance, or quantitative data are provided in the filing summary.
04-02-2026
International Land Alliance Inc. filed a Form 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, Item 5.07 submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed. This multi-item filing provides governance and shareholder-related updates without specified positive or negative impacts.
04-02-2026
NightFood Holdings, Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or quantitative data were disclosed in the provided filing summary. The nature of the Regulation FD disclosure and contents of any exhibits remain NOT_DISCLOSED.
04-02-2026
Lamb Weston Holdings, Inc. filed an 8-K on 2026-02-04 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or quantitative data are disclosed.
04-02-2026
Brookfield Asset Management Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02 and departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. Financial statements and exhibits are referenced under Item 9.01. No specific details on leadership changes, financial metrics, names, positions, reasons, or quantitative data are disclosed in the provided filing information.
04-02-2026
CECO Environmental Corp filed an 8-K on 2026-02-04 reporting entry into a Material Definitive Agreement under Item 1.01 and creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement under Item 2.03. Item 9.01 provides Financial Statements and Exhibits. No quantitative details, terms, positive or negative metrics, or directional impacts are disclosed.
- Β·AccNo: 0001193125-26-036815
- Β·File Size: 2 MB
- Β·Multi-item mandatory 8-K filing
04-02-2026
Piper Sandler Companies filed an 8-K on 2026-02-04 disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.
04-02-2026
NATURAL HEALTH TRENDS CORP filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, or other financial metrics are disclosed in the filing details provided. No positive or negative performance indicators, guidance, or material events are mentioned.
04-02-2026
CERO Therapeutics Holdings, Inc. filed Form 8-K on 2026-02-04 reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed.
04-02-2026
NRG Energy, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
04-02-2026
Dayforce, Inc. filed an 8-K on 2026-02-04 disclosing completion of an acquisition or disposition of assets (Item 2.01) alongside entry into a new material definitive agreement (Item 1.01), but also termination of another material definitive agreement (Item 1.02), notice of delisting or failure to satisfy listing standards (Item 3.01), and changes in control of the registrant (Item 5.01). Additional disclosures include unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), and Regulation FD disclosure (Item 7.01). No financial terms, parties, valuations, or quantitative metrics were explicitly stated.
04-02-2026
CHOICEONE FINANCIAL SERVICES INC filed an 8-K on 2026-02-04 related to an officer change, including Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the key position affected, whether it is an appointment or resignation, reason for the change, timing, or any named executives are disclosed. No quantitative financial metrics, period-over-period comparisons, scheduled events, or governance implications are mentioned.
- Β·AccNo: 0000905729-26-000032
- Β·File Size: 5 MB
- Β·Event Type: Officer Change
- Β·Item 5.02 (typical for officer changes) not explicitly listed
04-02-2026
MSC Income Fund, Inc. filed an 8-K on February 4, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- Β·Filing AccNo: 0001535778-26-000016
- Β·File size: 294 KB
- Β·Sector: not specified
04-02-2026
VSE Corp filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-036858) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed. This is a multi-item mandatory filing with no quantitative data provided.
04-02-2026
Eagle Bancorp Montana, Inc. filed an 8-K on February 4, 2026, reporting under Item 7.01 Regulation FD Disclosure, which is a voluntary disclosure to ensure broad dissemination of material information. Item 9.01 indicates financial statements and exhibits are attached, but no specific details, metrics, transactions, or events are disclosed in the filing summary. No quantitative financial impacts, guidance changes, or scheduled events are mentioned.
04-02-2026
First Northwest Bancorp filed a Form 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary disclosure with attached materials, but content is NOT_DISCLOSED.
04-02-2026
GBank Financial Holdings Inc. filed an 8-K on February 4, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary public release of material nonpublic information. Item 9.01 lists Financial Statements and Exhibits, but specific details, metrics, or content are NOT_DISCLOSED. No financial impacts, transactions, or performance data are provided in the filing summary.
04-02-2026
NB Bancorp, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010122, size 7 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or contents of the exhibits are disclosed. This is a multi-item informational filing with no financial metrics, transactions, or performance data provided.
04-02-2026
MAGELLAN COPPER & GOLD Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001683168-26-000744, Size: 195 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the 'Other Event', transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item, likely voluntary disclosure with no quantified impacts mentioned.
04-02-2026
Tyler Technologies Inc filed an 8-K on February 4, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. The core event details under Item 8.01 are NOT_DISCLOSED, and no specific financial statements, exhibits, or quantitative metrics are described in the filing summary. This appears to be a multi-item informational filing with no disclosed positive or negative performance metrics.
04-02-2026
Oncolytics Biotech Inc. filed a Form 8-K on February 4, 2026, reporting solely under Item 8.01 Other Events. No details on the core event, transaction values, financial metrics, positive or negative impacts, or quantitative data are disclosed in the provided filing information. This is a single-item filing with no specified sector context.
04-02-2026
Nordicus Partners Corp filed an 8-K on February 4, 2026, reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. Critical quantitative and qualitative data is NOT_DISCLOSED.
- Β·Item 8.01 used for unspecified other events, which may indicate voluntary disclosure of material information.
- Β·Item 9.01 indicates exhibits or financial statements attached, but contents NOT_DISCLOSED.
04-02-2026
i-80 Gold Corp. filed an 8-K on 2026-02-04 disclosing an officer change or departure under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any financial metrics are disclosed in the provided filing information.
04-02-2026
Landmark Bancorp Inc filed an 8-K on February 4, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the core event, financial metrics, transactions, or performance changes (positive, negative, or flat) are disclosed in the provided filing summary. This filing ensures compliance with Regulation FD for sharing material information.
04-02-2026
WAFD INC filed an 8-K on 2026-02-04 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, such as key positions affected, appointment or resignation reasons, board meeting outcomes, or quantitative metrics, are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.
- Β·AccNo: 0000936528-26-000023
- Β·File Size: 209 KB
- Β·Sector: NOT_DISCLOSED
04-02-2026
Maison Solutions Inc. filed an 8-K on February 04, 2026, disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 provides financial statements and exhibits. No specific deal terms, parties, valuations, or financial impacts are disclosed.
04-02-2026
ARTS WAY MANUFACTURING CO INC filed an 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are mentioned in the provided filing details. This is a multi-item, likely voluntary earnings-related disclosure with no quantified financial impacts disclosed.
04-02-2026
OKMIN RESOURCES, INC. filed a Form 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits (AccNo: 0001079973-26-000165, Size: 677 KB). No details on the agreement, transaction value, parties, financial impacts, or metrics are provided in the filing summary. This is a multi-item mandatory disclosure of a material event.
04-02-2026
KEMPER Corp filed an 8-K on February 04, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 financial statements and exhibits. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a standard voluntary earnings-related disclosure with no directional financial impacts detailed.
04-02-2026
Golub Capital BDC, Inc. filed an 8-K on February 04, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or guidance details are provided in the filing summary. This is a standard informational disclosure for financial results without quantified metrics.
04-02-2026
ALT5 Sigma Corp filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or any quantitative impacts were disclosed.
04-02-2026
SiTime Corp filed an 8-K on February 04, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing summary. This appears to be a standard mandatory earnings-related disclosure without detailed performance data.
- Β·Multi-item 8-K filing (Items 2.02 and 9.01)
- Β·AccNo: 0001451809-26-000007, Size: 383 KB
- Β·Event Type: Financial Results
04-02-2026
Hewlett Packard Enterprise Co filed an 8-K on February 4, 2026 (AccNo: 0001645590-26-000006, Size: 180 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, quantitative data, period-over-period comparisons, or other details are explicitly stated in the provided filing information. This is an informational disclosure with no positive or negative metrics disclosed.
04-02-2026
AMERICAN SUPERCONDUCTOR CORP /DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure typical for earnings announcements, but specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED. No positive or negative performance indicators, period-over-period comparisons, or balance sheet effects are provided in the filing summary.
04-02-2026
DIGI International Inc filed an 8-K on February 4, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing focused on financial results announcement.
04-02-2026
U S PHYSICAL THERAPY INC /NV filed a Form 8-K on February 4, 2026 (AccNo: 0000885978-26-000006, Size: 809 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. All quantitative and qualitative event specifics are NOT_DISCLOSED.
04-02-2026
Boot Barn Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001104659-26-010309), reporting results of operations and financial condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or operational details are available.
04-02-2026
Kulicke & Soffa Industries Inc filed an 8-K on February 4, 2026 (AccNo: 0000056978-26-000010), disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard financial results announcement with sector not specified.
04-02-2026
Global AI, Inc. filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.
04-02-2026
Lesaka Technologies Inc filed an 8-K on February 4, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
Lifevantage Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition (Item 2.02), a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements (Item 5.02), and financial statements and exhibits (Item 9.01). No specific details on the officer change, including key position, appointment or resignation status, reasons, timing, or any financial metrics are explicitly stated. No quantitative data, period-over-period comparisons, or scheduled events were disclosed.
04-02-2026
HYCROFT MINING HOLDING CORP filed a Form 8-K on 2026-02-04 disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by financial statements and exhibits under Item 9.01. No quantitative financial metrics, transaction details, or specific changes are disclosed. This appears to be an informational governance update without evident positive or negative performance indicators.
04-02-2026
04-02-2026
McKesson Corp filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and providing Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed quantitative data available.
04-02-2026
04-02-2026
TTM Technologies Inc filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.
04-02-2026
Accuray Inc filed a Form 8-K on February 4, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results from operations but no specific revenue, earnings, or other quantitative metrics are provided in the filing details. No period-over-period comparisons, guidance, or directional performance indicators (positive, negative, or flat) are mentioned.
04-02-2026
Align Technology Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001097149-26-000006), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without detailed operational or financial data available for analysis.
04-02-2026
Aligos Therapeutics, Inc. filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037558, Size: 137 KB) disclosing Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, appointment or resignation status, reasons for change, timing, or any quantitative metrics are provided. This is a routine SEC-required disclosure for material leadership events with no additional context available.
- Β·Filing Accession Number: 0001193125-26-037558
- Β·Filing Size: 137 KB
- Β·Event Date: 2026-02-04
- Β·Sector: NOT_DISCLOSED
04-02-2026
Coherent Corp. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided information. Detailed operational or balance sheet impacts are NOT_DISCLOSED.
04-02-2026
ALICO, INC. filed a Form 8-K on February 4, 2026 (AccNo: 0000003545-26-000010, Size: 464 KB), disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, transaction details, or guidance are explicitly stated in the provided filing summary. This appears to be a standard earnings-related disclosure with attached exhibits.
04-02-2026
04-02-2026
PC Connection Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but specific quantitative metrics such as revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED. No positive or negative performance indicators, scheduled events, or forward-looking statements are detailed in the provided filing information.
04-02-2026
UNIVERSAL TECHNICAL INSTITUTE INC filed an 8-K on February 04, 2026, under Item 2.02 for Results of Operations and Financial Condition, Item 7.01 for Regulation FD Disclosure, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information.
04-02-2026
FormFactor Inc. filed an 8-K on February 4, 2026 (AccNo: 0001039399-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a standard earnings release disclosure. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item filing with no period-over-period comparisons, positive/negative changes, or flat performance data available.
04-02-2026
Symbotic Inc. filed an 8-K on February 04, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item earnings-related disclosure. Specific financial metrics, performance comparisons, or guidance details are NOT_DISCLOSED.
04-02-2026
PagerDuty, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. Specific details on the affected position, individual name, appointment or resignation, reasons, or timing are NOT_DISCLOSED.
04-02-2026
Workday, Inc. filed a Form 8-K on 2026-02-04 under Item 2.02 (Results of Operations and Financial Condition), Item 2.05 (Costs Associated with Exit or Disposal Activities), and Item 2.06 (Material Impairments), indicating a multi-item disclosure. While results of operations may include performance updates, the presence of exit/disposal costs and material impairments points to negative financial pressures such as restructuring and asset write-downs. Specific metrics, dollar values, or period-over-period comparisons are NOT_DISCLOSED.
04-02-2026
SUNation Energy, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on the nature of the agreement, financial obligation, transaction value, or any quantitative impacts are NOT_DISCLOSED. No revenue, earnings, balance sheet effects, guidance changes, or other metrics provided.
04-02-2026
Golub Capital BDC, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, with Financial Statements and Exhibits attached under Item 9.01. No specific financial metrics, period-over-period comparisons, revenue, earnings, balance sheet details, or guidance changes are disclosed in the provided filing summary. This is a standard voluntary disclosure for financial results with no quantitative data available for analysis.
04-02-2026
Allegiant Travel Company filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the filing summary. This multi-item filing provides informational disclosure without quantified metrics.
04-02-2026
QUALCOMM INC/DE filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance metrics.
04-02-2026
Eureka Acquisition Corp filed an 8-K on 2026-02-04 disclosing entry into a Material Definitive Agreement under Item 1.01, likely related to a merger or acquisition event. The filing also reports creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. No specific quantitative metrics, parties involved, deal terms, or performance comparisons are disclosed.
04-02-2026
Clearfield, Inc. filed a Form 8-K on 2026-02-04 reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item mandatory disclosure typical for quarterly or annual earnings releases.
04-02-2026
Everest Group, Ltd. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics are mentioned. All detailed financial performance data is NOT_DISCLOSED.
- Β·AccNo: 0001095073-26-000003
- Β·File Size: 877 KB
- Β·Sector: NOT_DISCLOSED
04-02-2026
A10 Networks, Inc. filed a Form 8-K on February 04, 2026 (AccNo: 0001580808-26-000005), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed. No positive or negative performance details, period-over-period comparisons, or transaction values are provided.
04-02-2026
Lipella Pharmaceuticals Inc. filed an 8-K on February 4, 2026 (AccNo: 0001753926-26-000265), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected position (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, named individuals, or any quantitative data such as compensation amounts are disclosed. Sector information is NOT_DISCLOSED.
04-02-2026
AquaBounty Technologies Inc. filed an 8-K on 2026-02-04 disclosing Item 5.01 Changes in Control of Registrant and Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or compensatory terms are disclosed. No financial metrics, performance data, or quantitative information provided.
04-02-2026
Omega Healthcare Investors Inc filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information.
04-02-2026
RMR Group Inc. filed an 8-K on February 4, 2026 (AccNo: 0001644378-26-000006), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative financial data were explicitly stated in the provided filing information. This represents a standard voluntary earnings disclosure without detailed performance metrics available.
04-02-2026
Great Elm Group, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides informational disclosure on financial results, but no specific revenue, earnings, margins, comparisons, or other metrics are mentioned. No positive or negative performance indicators, guidance, or scheduled events are detailed.
04-02-2026
Crown Castle Inc. filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. The presence of Item 2.05 signals potential negative costs from restructuring or disposal efforts, while Item 2.02 covers financial results, but no specific revenue, earnings, or cost figures are disclosed. This multi-item filing provides transparency on operations and potential restructuring but lacks quantified metrics for impact assessment.
04-02-2026
Howard Hughes Holdings Inc. filed an 8-K on 2026-02-04 (AccNo: 0001104659-26-010321, size: 227 KB) reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary.
04-02-2026
Allstate Corp filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure without quantified positive or negative changes.
04-02-2026
CENTRAL GARDEN & PET CO filed a Form 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information.
04-02-2026
CORPAY, INC. filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided information. This is a multi-item filing typical for quarterly earnings releases with no quantitative metrics available.
04-02-2026
UGI Corp (/PA/) filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010315), reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No specific vote outcomes, proposals, share counts, or quantitative results are disclosed in the provided filing information. This is a single-item informational filing with no financial metrics or period-over-period comparisons mentioned.
04-02-2026
Lucky Strike Entertainment Corp filed an 8-K on February 04, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No quantitative financial metrics, revenue, earnings, guidance, period-over-period comparisons, or balance sheet details were explicitly stated in the provided filing information. Sector is not specified.
04-02-2026
Moelis & Co (sector not specified) filed an 8-K on 2026-02-04 (AccNo: 0001193125-26-037612, Size: 1 MB) under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are mentioned.
04-02-2026
Firefly Neuroscience, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement under Item 1.01 and departure/election of directors or certain officers, including compensatory arrangements of certain officers under Item 5.02. Item 9.01 includes financial statements and exhibits. No specific transaction details, financial metrics, or quantitative impacts are disclosed.
04-02-2026
Revolve Group, Inc. filed an 8-K on 2026-02-04 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant). Item 9.01 discloses Financial Statements and Exhibits. No transaction details, dollar values, financial metrics, or impacts are provided.
04-02-2026
BANK OF THE JAMES FINANCIAL GROUP INC filed an 8-K on February 4, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of financial results without detailed directional data.
04-02-2026
PTC Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037588), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or other quantitative details are provided in the filing summary. This is a standard voluntary earnings-related disclosure with no disclosed positive or negative performance indicators.
04-02-2026
Equitable Holdings, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No positive or negative performance details, period-over-period comparisons, or guidance changes are provided in the available information.
04-02-2026
TransMedics Group, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.
04-02-2026
e.l.f. Beauty, Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics are disclosed in the provided filing information.
04-02-2026
Crown Holdings, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed metrics available.
04-02-2026
Kinsale Capital Group, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on affected positions, individuals, reasons, or impacts are disclosed.
04-02-2026
CuriosityStream Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or contents of the exhibits are disclosed in the provided filing summary. This is an informational filing with no quantitative financial metrics, positive or negative changes, or material impacts explicitly stated.
04-02-2026
Bassett Furniture Industries Inc filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.
04-02-2026
Snap Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001564408-26-000011, Size: 5 MB), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This appears to be a standard multi-item earnings-related disclosure.
04-02-2026
Helmerich & Payne, Inc. filed a Form 8-K on 2026-02-04 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a standard earnings-related filing, but no specific quantitative financial metrics, period-over-period comparisons, or directional performance data (positive, negative, or flat) are provided in the filing summary. No revenue, earnings, guidance, or balance sheet impacts are detailed.
04-02-2026
Blue Bird Corp filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. This multi-item filing provides no period-over-period comparisons or directional performance indicators.
04-02-2026
Fluence Energy, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing related to financial results announcement. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.
04-02-2026
EZCORP INC filed a Form 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating disclosure of financial results likely via attached press release or statements. This is a multi-item filing focused on earnings-related information with no specific revenue, earnings, or other quantitative metrics detailed. No positive or negative performance indicators, guidance, or comparisons were provided in the filing metadata.
04-02-2026
StoneX Group Inc. filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance data available.
04-02-2026
Ensign Group, Inc. filed an 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or quantitative financial metrics are disclosed in the provided filing information.
04-02-2026
Lantronix Inc filed an 8-K on February 4, 2026 (AccNo: 0001683168-26-000750), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, quantitative data, period-over-period comparisons, or other details are provided in the filing summary.
- Β·Sector: NOT_DISCLOSED
04-02-2026
NETGEAR, INC. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037642), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other metrics are disclosed in the provided filing information.
04-02-2026
Rexford Industrial Realty, Inc. filed a Form 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific financial metrics, period-over-period changes, guidance, or other quantitative data are provided in the filing summary. No positive or negative performance indicators are available.
04-02-2026
Greenbrier Companies Inc filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific details on the nature of the agreement, transaction size, parties involved, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
04-02-2026
PVH Corp. /DE/ filed an 8-K on February 4, 2026 (AccNo: 0000078239-26-000005, size 190 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial metrics, or exhibits are disclosed. This appears to be a multi-item filing likely including attached documents such as a press release.
04-02-2026
COPT DEFENSE PROPERTIES filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer, position, reason, timing, or any quantitative data are disclosed.
04-02-2026
Tenable Holdings, Inc. filed an 8-K on February 04, 2026, under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Detailed financial metrics, transaction values, or operational impacts are NOT_DISCLOSED.
04-02-2026
Monarch Casino & Resort Inc filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, period-over-period changes, guidance, or other quantitative details are disclosed in the provided filing information. This appears to be a multi-item filing announcing financial results with attached exhibits.
04-02-2026
Mueller Water Products, Inc. filed an 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. No specific revenue, earnings, margins, guidance, or period-over-period metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified performance data.
04-02-2026
NLIGHT, INC. filed a Form 8-K on 2026-02-04 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing information. This appears to be an informational filing with attached exhibits, but core event content is not available.
04-02-2026
Modine Manufacturing Co filed an 8-K on February 4, 2026 (AccNo: 0001104659-26-010338, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard voluntary disclosure of financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing summary.
04-02-2026
Launchpad Cadenza Acquisition Corp I filed an 8-K on 2026-02-04 disclosing a merger/acquisition event under Item 8.01 (Other Events) and providing financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, financial impacts, positive or negative performance indicators, or period-over-period comparisons are disclosed in the provided filing summary. Critical details such as parties involved, valuation, structure, and strategic rationale remain NOT_DISCLOSED.
04-02-2026
Pacific Oak Strategic Opportunity REIT, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 2.04 a triggering event that accelerates or increases a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific details on the nature of the event, dollar value, financial impact, or related metrics were disclosed. This mandatory disclosure signals potential financial stress but lacks quantification for precise assessment.
04-02-2026
Globe Life Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics were mentioned in the provided filing information. This appears to be a standard earnings-related disclosure with no detailed performance data available.
- Β·AccNo: 0000320335-26-000029
- Β·Filing size: 647 KB
- Β·Sector: not specified
04-02-2026
Stewart Information Services Corp filed an 8-K on February 04, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard voluntary earnings-related disclosure with AccNo: 0001104659-26-010325 and file size 566 KB.
04-02-2026
Noodles & Co filed a Form 8-K on February 4, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on vote outcomes, the nature of other events, or contents of exhibits are disclosed. This multi-item filing provides informational disclosure without quantified financial metrics or directional impacts.
04-02-2026
Gladstone Capital Corp filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037714), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, or other quantitative metrics are provided in the filing summary. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.
04-02-2026
GenFlat Holdings, Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are provided in the available information. This is a multi-item filing with no quantitative data or performance metrics disclosed.
04-02-2026
GigCapital7 Corp. filed an 8-K on February 04, 2026, reporting under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, under Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory disclosure of potentially material events, but no specific transaction sizes, dollar values, share counts, or financial impacts are disclosed. No positive or negative metrics are provided, resulting in informational disclosure without directional bias.
04-02-2026
Krispy Kreme, Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or implications are disclosed. This is a routine disclosure with no quantitative metrics, positive or negative changes reported.
04-02-2026
USCB Financial Holdings, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals involved, reasons for change, or quantitative data are disclosed.
04-02-2026
Victory Capital Holdings, Inc. filed an 8-K on February 4, 2026 (AccNo: 0001193125-26-037708), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
WEX Inc. filed an 8-K on February 4, 2026 (AccNo: 0001309108-26-000005), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without quantified performance details.
04-02-2026
Columbus McKinnon Corp filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement (Item 1.01), termination of a prior material definitive agreement (Item 1.02), completion of an acquisition or disposition of assets (Item 2.01), creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), changes in directors or officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). The filing signals a merger/acquisition event but includes both positive developments like acquisition completion and potentially negative ones like agreement termination and new financial obligations. Specific details on parties, deal structure, values, and impacts are NOT_DISCLOSED.
04-02-2026
Alliance Resource Partners LP filed an 8-K on 2026-02-04 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits, likely including the agreement document. No specific details on the agreement terms, transaction value, parties, financial impacts, or metrics are disclosed.
04-02-2026
Aramark filed an 8-K on February 4, 2026, specifically reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a mandatory disclosure of shareholder vote results from a recent meeting. No specific proposals, vote outcomes, numerical results, or other details are disclosed.
04-02-2026
ePlus inc filed a Form 8-K on February 4, 2026 (AccNo: 0001022408-26-000017), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. This multi-item filing pertains to financial results but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided details. No positive or negative performance indicators, period-over-period changes, or balance sheet impacts are mentioned.
04-02-2026
American Healthcare REIT, Inc. filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or any quantitative metrics are disclosed.
- Β·Filing accession number: 0001193125-26-037696
- Β·Filing size: 214 KB
04-02-2026
O'Reilly Automotive Inc. filed a Form 8-K on February 4, 2026, reporting results of operations and financial condition under Item 2.02 and attaching financial statements and exhibits under Item 9.01. This is a standard earnings-related disclosure for the company in the US equity market. Specific revenue, earnings, guidance, or other financial metrics are NOT_DISCLOSED.
04-02-2026
STERIS plc filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the filing description. This appears to be a standard earnings-related disclosure with exhibits likely containing detailed financial statements.
04-02-2026
Murphy USA Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001573516-26-000026), under Item 2.02 disclosing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are provided in the filing summary. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
Asbury Automotive Group Inc filed an 8-K on February 04, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers, and Item 5.03 disclosing amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 indicates financial statements and exhibits were included. No specific details on individuals affected, reasons for changes, financial impacts, or quantitative metrics are disclosed.
04-02-2026
Stifel Financial Corp filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided.
04-02-2026
IF Bancorp, Inc. filed a Form 8-K on February 04, 2026, reporting under Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on voting outcomes, events, financial statements, or exhibits are disclosed. No quantitative metrics, transactions, or performance data provided.
04-02-2026
Silgan Holdings Inc filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005470), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
04-02-2026
bioAffinity Technologies, Inc. filed a Form 8-K on 2026-02-04 under Item 8.01 Other Events. No details regarding the specific nature of the event, financial metrics, transactions, or operational impacts are disclosed in the provided filing information. Sector is not specified, and no quantitative data or comparisons are mentioned.
04-02-2026
WRAP Technologies, Inc. filed a Form 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, dollar values, share counts, or financial impacts for these items are disclosed. This is a multi-item filing with no period-over-period comparisons or guidance provided.
04-02-2026
Post Holdings, Inc. filed a Form 8-K on February 4, 2026, disclosing events under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing reports governance-related changes and outcomes from a shareholder vote, but no specific details, vote results, amendment descriptions, or financial metrics are provided in the available information. No positive or negative performance metrics are mentioned.
04-02-2026
Adial Pharmaceuticals, Inc. filed an 8-K on February 4, 2026, reporting under Item 3.03 material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details, transaction values, financial metrics, positive or negative changes, or period-over-period comparisons disclosed. No quantitative impacts or directional biases are evident from the available information.
04-02-2026
Coeptis Therapeutics Holdings, Inc. filed an 8-K on February 04, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. No specific proposals, vote outcomes, or numerical results are disclosed in the provided filing information. No financial metrics, changes, or other quantitative data are mentioned.
04-02-2026
Middleby Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or quantitative impacts are disclosed.
04-02-2026
XTI Aerospace, Inc. filed an 8-K on 2026-02-04 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01), alongside changes in directors or certain officers including compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, deal values, parties involved, or performance comparisonsβpositive, negative, or flatβare provided in the filing summary. This informational filing signals a completed material transaction but lacks details to assess impact.
- Β·AccNo: 0001213900-26-012273
- Β·File size: 867 KB
04-02-2026
Wolfspeed, Inc. filed an 8-K on February 4, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data available.
04-02-2026
Flowco Holdings Inc. filed a Form 8-K on February 04, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. This multi-item filing provides limited informational disclosure without quantified impacts.
04-02-2026
Maze Therapeutics, Inc. filed a Form 8-K on February 04, 2026, reporting entry into a new material definitive agreement under Item 1.01, termination of a prior material definitive agreement under Item 1.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. This multi-item filing signals significant contractual changes and new obligations, but no specific details, dollar values, or strategic context were disclosed. The combination suggests potential strategic shifts offset by new financial commitments.
04-02-2026
Regional Management Corp. filed a Form 8-K on 2026-02-04 reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information. This is a multi-item filing typical for earnings announcements, but lacks detailed performance data for analysis.
04-02-2026
Standex International Corp/DE/ filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits). This is a standard disclosure of financial results with attached exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are disclosed in the provided filing information.
04-02-2026
Grayscale CoinDesk Crypto 5 ETF filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037738, Size: 162 KB) under Item 8.01 reporting Other Events. No specific details on the nature of the event, transaction values, financial metrics, positive or negative impacts, or comparisons are disclosed. Sector is not specified.
04-02-2026
Cerence Inc. filed an 8-K on February 4, 2026 (AccNo: 0001628280-26-005491), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings announcements, with file size of 6 MB.
04-02-2026
iQSTEL Inc filed a Form 8-K on February 4, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details on vote matters, outcomes, the nature of other events, or exhibit contents are disclosed. No quantitative metrics, financial impacts, or directional biases are provided in the filing summary.
04-02-2026
Markel Group Inc. filed a Form 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item filing announcing financial results with no specific quantitative metrics, comparisons, positive or negative changes detailed in the provided information. No guidance, scheduled events, or other material details were explicitly stated.
04-02-2026
Phibro Animal Health Corp filed an 8-K on February 04, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard disclosure for financial results without detailed performance data.
04-02-2026
U-Haul Holding Co /NV/ filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, or other financial metrics were mentioned in the provided filing information. No positive, negative, or flat performance indicators are available.
04-02-2026
Uniti Group Inc. filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, or financial impacts are disclosed.
04-02-2026
Rubrik, Inc. filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), and financial statements/exhibits under Item 9.01. No specific details on the officer position affected, appointment/resignation status, reasons, timing, financial metrics, or quantitative data are disclosed. Sector is not specified.
04-02-2026
Kimball Electronics, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001606757-26-000006), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are mentioned in the provided filing description. This appears to be a standard voluntary earnings release without detailed performance data available.
04-02-2026
Core Laboratories Inc. filed an 8-K on February 4, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item voluntary disclosure typical for earnings releases. No specific revenue, earnings, or other financial metrics are disclosed.
04-02-2026
Compass Minerals International Inc filed an 8-K on February 4, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no detailed performance data available.
04-02-2026
ACM Research, Inc. filed an 8-K on February 04, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. This appears to be a multi-item voluntary disclosure with no quantified impacts mentioned.
04-02-2026
ASGN Inc filed an 8-K on February 4, 2026 (AccNo: 0000890564-26-000008), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing furnishing financial results. Specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are NOT_DISCLOSED.
04-02-2026
Matrix Service Co filed an 8-K on February 4, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are mentioned in the filing description. This is a standard informational disclosure for financial results with no directional data provided.
04-02-2026
FIRST UNITED CORP/MD/ filed a Form 8-K on 2026-02-04 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or quantitative metrics are disclosed in the provided filing information. This is a multi-item, likely voluntary disclosure related to earnings release.
04-02-2026
MetLife Inc filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific revenue, earnings, or other metrics are NOT_DISCLOSED. No positive or negative performance details provided.
04-02-2026
National Bank Holdings Corp filed an 8-K on February 04, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the Regulation FD disclosure or the attached exhibits are disclosed in the provided filing information.
04-02-2026
Orange County Bancorp, Inc. filed an 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a voluntary disclosure of financial results. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing details. This is purely informational without directional financial data.
04-02-2026
Southland Holdings, Inc. filed a Form 8-K on February 4, 2026 (AccNo: 0001829126-26-000959, Size: 261 KB), reporting under Item 8.01 Other Events. No specific details regarding the core event, transaction value, financial impacts, or metrics are disclosed in the provided filing information. No positive or negative performance metrics, guidance changes, or scheduled events are mentioned.
04-02-2026
FMC Corp filed an 8-K on 2026-02-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, balance sheet changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related filing with no directional performance indicators available.
04-02-2026
Evercore Inc. filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.
04-02-2026
SiTime Corp filed a Form 8-K on February 4, 2026 (AccNo: 0001193125-26-037802, Size: 6 MB), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing for the material agreement, with Regulation FD potentially voluntary if triggered. No specific details on the agreement terms, transaction value, financial impacts, or quantitative metrics are disclosed in the provided filing summary.
04-02-2026
Ralliant Corp filed a Form 8-K on February 4, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, margins, or other quantitative metrics. No positive or negative performance indicators, guidance, or comparisons are detailed in the provided filing information.
04-02-2026
Laser Photonics Corp filed an 8-K on 2026-02-04 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, appointment or resignation status, reasons for change, and any governance implications are NOT_DISCLOSED.
04-02-2026
GEOSPACE TECHNOLOGIES CORP filed an 8-K on February 4, 2026, under Item 2.02 announcing results of operations and financial condition, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. This appears to be a standard voluntary earnings release filing.
04-02-2026
Cadiz Inc filed an 8-K on 2026-02-04 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for changes, timing, or any financial metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no additional quantitative or qualitative context provided.
04-02-2026
CION Investment Corp filed an 8-K on February 4, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's parties, terms, value, or financial implications are provided. This is a multi-item mandatory filing with no quantitative metrics or performance comparisons disclosed.
04-02-2026
Confluent, Inc. filed a Form 8-K on February 4, 2026, under Item 8.01 disclosing Other Events. No details on the core event, financial impacts, quantitative metrics, or strategic implications were provided in the filing information. No positive or negative metrics mentioned.
04-02-2026
GAXOS.AI INC. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the other events or contents of the exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or impacts are mentioned.
04-02-2026
Space Asset Acquisition Corp. filed an 8-K on February 4, 2026 (AccNo: 0001213900-26-012366), disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, or strategic rationale were detailed in the filing summary provided. Sector details were not specified.
04-02-2026
Luminar Technologies, Inc./DE filed an 8-K on February 4, 2026, disclosing the termination of a material definitive agreement under Item 1.02 and the completion of an acquisition or disposition of assets under Item 2.01. Item 9.01 references financial statements and exhibits, but no specific financial metrics, parties, or terms were detailed. This filing provides informational updates on transactional events without quantified impacts.
04-02-2026
UPEXI, INC. filed an 8-K on February 4, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement terms, transaction value, parties involved, financial impacts, or other metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without quantitative data or directional implications.
04-02-2026
Envirotech Vehicles, Inc. filed an 8-K on February 4, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 5.07 submission of matters to a vote of security holders and Item 9.01 financial statements and exhibits. Specific details including names, positions affected, reasons for changes, voting outcomes, or exhibit contents are NOT_DISCLOSED.
04-02-2026
KRAKacquisition Corp filed an 8-K on 2026-02-04 (AccNo: 0001140361-26-003733, Size: 386 KB) disclosing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits in connection with a labeled Merger/Acquisition event. No deal structure, parties involved, valuation, financial terms, strategic rationale, synergies, regulatory pathway, or shareholder impacts are explicitly stated or quantified in the provided filing details. Sector is not specified, with no positive or negative metrics, comparisons, or scheduled events disclosed.
- Β·Critical missing information: Deal structure, parties (acquirer/target), valuation (equity/enterprise value), consideration type (cash/stock), strategic rationale, synergies, EPS impact, regulatory approvals, shareholder vote details, timeline, and sector context - all required for full M&A analysis
04-02-2026
GE Vernova Inc. filed a Form 8-K on February 4, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. No financial metrics, transactions, or performance data are mentioned, resulting in no identifiable positive or negative impacts.
04-02-2026
REGIONS FINANCIAL CORP filed an 8-K on February 04, 2026, reporting Item 5.03 regarding amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits, likely the amended documents. No quantitative financial metrics, transaction values, positive or negative changes, or specific details on the amendments were mentioned.
04-02-2026
Cumberland Pharmaceuticals Inc filed a Form 8-K on February 4, 2026 (AccNo: 0001087294-26-000011, Size: 180 KB), reporting solely under Item 8.01 Other Events. The core nature of the other event is NOT_DISCLOSED, with no financial metrics, quantitative data, period-over-period comparisons, or operational details provided. No positive, negative, or flat performance indicators are mentioned.
04-02-2026
Oracle Corp filed a Form 8-K on 2026-02-04 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details provided on the agreement, events, transaction value, financial impacts, or metrics. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.
04-02-2026
Vivakor, Inc. filed an 8-K on February 4, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or financial impacts provided. No quantitative metrics, period-over-period comparisons, or guidance changes are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 278 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC